SCHEMBL4963392

SCHEMBL4963392

CC(O)[C@@H]1CCN1C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
HPGD P15428 1/20 0.40
NR1H2 P55055 2/20 0.39
NR1H3 Q13133 2/20 0.39
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GPR119 Q8TDV5 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25156722 1.00 HSD17B10 (0.40) HSD17B10CHRM2CHRM1CHRM3HPGD
SCHEMBL26783131 1.00 HSD17B10 (0.40) HSD17B10CHRM2CHRM1CHRM3HPGD
SCHEMBL26782422 1.00 HSD17B10 (0.40) HSD17B10CHRM2CHRM1CHRM3HPGD
SCHEMBL30636997 1.00 HSD17B10 (0.40) HSD17B10CHRM2CHRM1CHRM3HPGD
SCHEMBL25156692 1.00 HSD17B10 (0.40) HSD17B10CHRM2CHRM1CHRM3HPGD
SCHEMBL25215473 0.90 HSD17B10 (0.48) HSD17B10HPGDSMN1; SMN2NPC1ALDH1A1
SCHEMBL19637426 0.90 HSD17B10 (0.48) HSD17B10HPGDSMN1; SMN2NPC1ALDH1A1
SCHEMBL25418925 0.90 HSD17B10 (0.48) HSD17B10HPGDSMN1; SMN2NPC1ALDH1A1
SCHEMBL13343679 0.90 HSD17B10 (0.48) HSD17B10HPGDSMN1; SMN2NPC1ALDH1A1
SCHEMBL19959341 0.90 HSD17B10 (0.48) HSD17B10HPGDSMN1; SMN2NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116997549-A Pyrrolo [3,2-C ] pyridin-4-one derivatives for the treatment of cancer 蝎子疗法股份有限公司 2023-11-03 CN disclosed
WO-2023064493-A1 COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES Clear Creek Bio, Inc. (US) 2023-04-20 WO disclosed
US-20080176826-A1 Pyridine Compounds For Combating Arthropod Pests and Nematodes BASF AKTIENGESELLSCHAFT (DE) 2008-07-24 US disclosed
EP-1891045-A2 PYRIDINE COMPOUNDS FOR COMBATING ARTHROPOD PESTS AND NEMATODES BASF AKTIENGESELLSCHAFT (DE) 2008-02-27 EP disclosed
WO-2006125641-A2 PYRIDINE COMPOUNDS FOR COMBATING ARTHROPOD PESTS AND NEMATODES BASF AKTIENGESELLSCHAFT (DE) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176826-A1 Pyridine Compounds For Combating Arthropod Pests and Nematodes C5, CHRM1, ACHE HSD17B10 3286/4885CHRM2 13/4885CHRM1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.